跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,008 条关于
“HER1”
全部
4,008
临床试验
3,266
药物
293
机构
3
资讯
446
8个月前
NERLYNX Launches in Thailand as New HER2+ Breast Cancer Treatment Option
上个月
Roche Canada and pCPA Complete Negotiations for Perjeta in Neoadjuvant HER2-Positive Early Breast Cancer
11个月前
Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License
去年
Taiho Pharmaceutical Advances TAS-0728, a Novel HER2/HER3 Inhibitor, for Multiple Solid Tumors
2年前
HER-Vaxx Plus Chemotherapy Shows Survival Benefit in HER2-Overexpressing Gastric Cancer
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
去年
Enhertu Approved for HER2-Low and HER2-Ultralow Metastatic Breast Cancer
去年
3D Pathology Technology Reclassifies 67% of HER2-Null Breast Cancer Cases as HER2-Expressing
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Overexpressing NSCLC
去年
HER2-Targeted Therapies Solidify Role in Early-Stage HER2-Positive Breast Cancer Treatment
第 1 页,共 45 页
上一页
下一页